Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?

To: Curtis E. Bemis who wrote (121)	4/7/1999 10:11:00 AM
From: Gregg	Read Replies (2) \| Respond to of 395

I heard some very big players are accumulating the stock. News coming that should push this stock to the $6-$8 range. Doctors that have tested the product can't stop talking about the great results. This stock is gonna go much higher. Good Luck Everyone.

To: Curtis E. Bemis who wrote (121)	4/21/1999 3:08:00 PM
From: Curtis E. Bemis	Read Replies (1) \| Respond to of 395

This was on the news wires yesterday-- CALIFORNIA DEPARTMENT OF DEVELOPMENTAL SERVICES REPORTS 273% INCREASE IN AUTISM POPULATION SINCE 1987 NEEDHAM, MA--April 20, 1999--Repligen Corporation (Nasdaq: RGEN) today today released highlights of a study conducted by the California Department of Developmental Services documenting a 273% increase in the number of autistic patients receiving services in this bellwether state. The study looked at the number of people with autism and other pervasive developmental disorders seeking services at 21 regional centers throughout California between 1987 and 1998, compared to patients with other disabilities. repligen.com